DURHAM, N.C., Aug. 23, 2022 (GLOBE NEWSWIRE) -- NightHawk Biosciences (NYSE American: NHWK), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the ...
ENFIELD, Conn.--(BUSINESS WIRE)--Eppendorf is proud to announce they have received Connecticut State approval to conduct Biosafety Level 2 (BL2) infectious disease related research. This greatly ...
The Centers for Disease Control and Prevention (CDC) just announced they are temporarily suspending work by lab scientists in BSL-4 (aka biosafety level 4) facilities. They recently learned their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback